[Nalidixic acid].
D000818:Animals; D001646:Bile / Q000032:analysis; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002002:Brucella / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D000882:Haplorhini; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D051379:Mice; D009268:Nalidixic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity / Q000652:urine; D010325:Pasteurella / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D051381:Rats; D012475:Salmonella / Q000187:drug effects; D012760:Shigella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid